Hemostasis in highlanders with excessive erythrocytosis at 5100 m: Preliminary data from the highest city of the world

Respir Physiol Neurobiol. 2020 Nov:282:103535. doi: 10.1016/j.resp.2020.103535. Epub 2020 Aug 29.

Abstract

Little is known about hemostasis modifications induced by chronic hypoxic exposure in high-altitude residents, especially in those who develop excessive erythrocytosis (EE, i.e. hemoglobin concentration ≥ 21 g·dL-1 in male and ≥ 19 g·dL-1 in female). The aim of this preliminary study was to assess coagulation alterations in highlanders with or without EE using simple hemostatic tests such as bleeding (BT) and clotting (CT) times. Eighty-one male (43 ± 7 years), permanent residents from La Rinconada (Peru), the highest city in the world (5,100-5,300 m), were evaluated. Thirty-six subjects (44 %) presented with EE. EE subjects compared to non-EE subjects had lower BT (3.6 ± 1.2 vs. 7.0 ± 1.9 min, p < 0.001) and CT (11.7 ± 1.7 vs. 15.1 ± 2.3 min, p < 0.001). These results support the notion that highlanders with EE are in a state of hypercoagulability and call for further hemostasis investigations in this population using more detailed hemostatic methods.

Keywords: Chronic mountain sickness; Coagulation; Excessive erythrocytosis; Hemostasis; High-altitude; Highlanders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Altitude Sickness / blood*
  • Altitude*
  • Blood Coagulation / physiology*
  • Hemostasis / physiology*
  • Humans
  • Male
  • Middle Aged
  • Peru
  • Polycythemia / blood*